Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FASN | P49327 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | FAAH | O00519 | 3/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | TERT | O14746 | 3/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.50 |
| ▸ | PPARG | P37231 | 3/20 | 0.50 |
| ▸ | PPARD | Q03181 | 3/20 | 0.50 |
| ▸ | PPARA | Q07869 | 3/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | BLM | P54132 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | FABP4 | P15090 | 2/20 | 0.50 |
| ▸ | GMNN | O75496 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30000546 | 1.00 | FASN (0.61) | FASNALDH1A1TSHRFAAHKDM4E | |
| SCHEMBL1427212 | 1.00 | FASN (0.61) | FASNALDH1A1TSHRFAAHKDM4E | |
| SCHEMBL29253334 | 1.00 | FASN (0.61) | FASNALDH1A1TSHRFAAHKDM4E | |
| SCHEMBL1427215 | 1.00 | FASN (0.61) | FASNALDH1A1TSHRFAAHKDM4E | |
| SCHEMBL1055870 | 1.00 | FASN (0.61) | FASNALDH1A1TSHRFAAHKDM4E | |
| SCHEMBL140063 | 1.00 | FASN (0.61) | FASNALDH1A1TSHRFAAHKDM4E | |
| SCHEMBL140696 | 1.00 | FASN (0.61) | FASNALDH1A1TSHRFAAHKDM4E | |
| SCHEMBL2732862 | 1.00 | FASN (0.61) | FASNALDH1A1TSHRFAAHKDM4E | |
| SCHEMBL15048699 | 1.00 | FASN (0.61) | FASNALDH1A1TSHRFAAHKDM4E | |
| SCHEMBL28614760 | 1.00 | FASN (0.61) | FASNALDH1A1TSHRFAAHKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 155 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230059978-A1 | LIVE CELL CONSTRUCTS FOR BIOSYNTHETIC MILK PRODUCTION AND RELATED PRODUCTS AND METHODS | GUILIANO SHAYNE (US) | 2023-02-23 | — | — | US | claimed |
| EP-4087915-A1 | LIVE CELL CONSTRUCTS FOR BIOSYNTHETIC MILK PRODUCTION AND RELATED PRODUCTS AND METHODS | Guiliano, Shayne (US) | 2022-11-16 | — | — | EP | claimed |
| WO-2021142241-A1 | LIVE CELL CONSTRUCTS FOR BIOSYNTHETIC MILK PRODUCTION AND RELATED PRODUCTS AND METHODS | GUILIANO SHAYNE (US) | 2021-07-15 | — | — | WO | claimed |
| US-9541565-B2 | Biomarkers for sensitive detection of statin-induced muscle toxicity | ZORA BIOSCIENCES OY (FI) | 2017-01-10 | — | — | US | claimed |
| EP-2405892-B1 | PHARMACEUTICAL FORMULATION COMPRISING KETOPROFEN AND A POLYOXYALKYLENE ESTER OF A HYDROXY FATTY ACID | ADVANCE HOLDINGS LTD (MT) | 2013-01-16 | — | — | EP | claimed |
| EP-2405892-A1 | PHARMACEUTICAL FORMULATION COMPRISING KETOPROFEN AND A POLYOXYALKYLENE ESTER OF A HYDROXY FATTY ACID | Advance Holdings Limited (MT) | 2012-01-18 | — | — | EP | claimed |
| US-20110275717-A1 | PHARMACEUTICAL FORMULATION COMPRISING DICLOFENAC | ADVANCE HOLDINGS LIMITED (MT) | 2011-11-10 | — | — | US | claimed |
| EP-2364140-A1 | PHARMACEUTICAL FORMULATION COMPRISING DICLOFENAC AND A HYDROXY FATTY ACID POLYOXYALKYLENE ESTER | Advance Holdings Limited (MT) | 2011-09-14 | — | — | EP | claimed |
| EP-2254667-A2 | TREATMENT OF DISEASES AND CONDITIONS MEDIATED BY EICOSANOIDS | Natural Environment Research Council (GB) | 2010-12-01 | — | — | EP | claimed |
| WO-2010102862-A1 | PHARMACEUTICAL FORMULATION COMPRISING KETOPROFEN AND A POLYOXYALKYLENE ESTER OF A HYDROXY FATTY ACID | ADVANCE HOLDINGS LIMITED (MT) | 2010-09-16 | — | — | WO | claimed |
| WO-2010060798-A1 | PHARMACEUTICAL FORMULATION COMPRISING DICLOFENAC AND A HYDROXY FATTY ACID POLYOXYALKYLENE ESTER | ADVANCE HOLDINGS LIMITED (MT) | 2010-06-03 | — | — | WO | claimed |
| WO-2009098454-A2 | TREATMENT OF DISEASES AND CONDITIONS MEDIATED BY EICOSANOIDS | NATURAL ENVIRONMENT RESEARCH COUNCIL (GB) | 2009-08-13 | — | — | WO | claimed |
| EP-3544684-B1 | PERSONALIZED METABOLOMIC PROFILING OF SPECIALIZED PRO-RESOLVING MEDIATORS | BRIGHAM & WOMENS HOSPITAL INC (US) | 2025-09-17 | — | — | EP | disclosed |
| US-20250281926-A1 | SAMPLE MANIPULATION AND ASSAY WITH RAPID TEMPERATURE CHANGE | ESSENLIX CORPORATION (US) | 2025-09-11 | — | — | US | disclosed |
| WO-2025151582-A1 | SYSTEM AND METHOD FOR BONE MARROW HEMATOPOESIS AND LEUKOCYTE MOBILIZATION | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2025-07-17 | — | — | WO | disclosed |
| US-20250099965-A1 | RAPID SAMPLE TEMPERATURE CHANGING FOR ASSAYING | ESSENLIX CORPORATION (US) | 2025-03-27 | — | — | US | disclosed |
| WO-1999062459-A9 | AGENTS AND METHODS FOR PROTECTION, TREATMENT AND REPAIR OF CONNECTIVE TISSUE | NUTRAMAX LAB INC (US) | 2000-04-27 | — | — | WO | disclosed |
| WO-1999062459-A2 | AGENTS AND METHODS FOR PROTECTION, TREATMENT AND REPAIR OF CONNECTIVE TISSUE | NUTRAMAX LABORATORIES, INC. (US) | 1999-12-09 | — | — | WO | disclosed |
| WO-1999040926-A1 | AGENTS AND METHODS FOR PROTECTION, TREATMENT AND REPAIR OF CONNECTIVE TISSUE | NUTRAMAX LABORATORIES, INC. (US) | 1999-08-19 | — | — | WO | disclosed |
| US-5334736-A | Functionalizing carbohydrate derivatives by base-induced β-eliminatiom forming bioactive derivatives containing hydroxy-diene subunits | UNIVERSITY OF TEXAS SYSTEM BOARD OF REGENTS (US) | 1994-08-02 | — | — | US | disclosed |